Key Highlights of the Transaction

• Completion of Acquisition: The company has completed the acquisition of a 70% equity interest in the Target Company.
• Transaction Value: The total consideration for the acquisition is RMB2,100,000.
• Date of Completion: The acquisition was finalized on 3 March 2026.
• Relevant Announcements: Details of the transaction were previously disclosed in announcements dated 31 December 2025, 8 January 2026, 22 January 2026, and 23 January 2026.

Potential Price-Sensitive Information for Shareholders

• Strategic Impact: The acquisition of a majority stake in the Target Company is a significant step in expanding the business scope and operational capacity of China Tian Yuan Healthcare Group Limited. Such M&A activities often signal management confidence and potential growth, which can be price-sensitive.
• Board Composition: As of 3 March 2026, the Board comprises five directors:
  • Ms. Dong Wei (Executive Director)
  • Ms. He Mei (Non-executive Director)
  • Mr. Yuen Kwok Kuen (Independent Non-executive Director)
  • Ms. Zhou Siqi (Independent Non-executive Director)
  • Mr. Li Jun (Independent Non-executive Director)

What Investors Should Watch

• Growth Prospects: The acquisition may open new revenue streams and enhance the company’s competitiveness in the healthcare sector. Investors should monitor future disclosures concerning the integration and performance of the Target Company.
• Financial Impact: While the consideration amount is relatively modest, the acquisition’s impact on future financial results and corporate strategy could be substantial. Shareholders are advised to follow subsequent announcements for updates on financial performance.

Conclusion

The completion of this acquisition is a noteworthy development for China Tian Yuan Healthcare Group Limited, reflecting an active approach to business expansion and sector consolidation. Investors should consider the potential strategic benefits and remain alert to further updates that may affect the company’s valuation.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should consult their financial advisors and review company filings before making investment decisions. The author and publisher take no responsibility for any investment actions taken based on this content.

View TIANYUAN HEALTH Historical chart here